Actigraphic measurements in opioid detoxification with methadone or buprenorphine

Journal of Clinical Psychopharmacology

Volumn 32, Issue 1, 2012, Pages 75-82

  Pjrek, Edda ^a   Frey, Richard ^a   Naderi Heiden, Angela ^a   Strnad, Alexandra ^a   Kowarik, Alexander ^b   Kasper, Siegfried ^a   Winkler, Dietmar ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Data Analysis OG   (Austria)

Author keywords

actigraphy; activity; opioid dependence; sleep wake cycle; withdrawal symptoms

Indexed keywords

BUPRENORPHINE; LOFEXIDINE; METHADONE; QUETIAPINE; VALPROIC ACID;

ACTIMETRY; ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DETOXIFICATION; FEMALE; HUMAN; MALE; NATURALISTIC INQUIRY; OPIATE ADDICTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REST; SLEEP WAKING CYCLE; TREATMENT DURATION; TREATMENT OUTCOME;

ACTIGRAPHY; ADULT; AUSTRIA; BUPRENORPHINE; CIRCADIAN RHYTHM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LENGTH OF STAY; MALE; METHADONE; OPIATE SUBSTITUTION TREATMENT; SLEEP;

EID: 84855347802     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31823f91d1     Document Type: Article

References (45)

1. United Nations, Office on Drugs and Crime. World Drug Report 2006. Vienna, Austria: United Nations Publications; 2006; ISBN 9211482143 (Volume 1), ISBN 9211482151 (Volume 2).
2. Naderi-Heiden A, Gleiss A, Bäcker C, et al. Mortality and employment after in-patient opiate detoxification. Eur Psychiatry. 2010 [Epub ahead of print]. Doi: 10.1016/j.eurpsy.2010.05.002.
3. Haas S, Busch M, Horvath I, et al. Bericht zur Drogensituation 2005. Wien: Ö sterreichisches Bundesinstitut für Gesundheitswesen; 2005.
4. O'Brien CP, Woody GE, McLellan AT. Long-term consequences of opiate dependence. N Engl J Med. 1981;304:1098-1099.
5. World Health Organization, United Nations Office on Drugs and Crime, UNAIDS. Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS Prevention: Position Paper. Geneva, Switzerland: WHO; 2004.
6. Fischer G, Kayer B. Substanzabhängigkeit vom MorphintypVstate-of- the-Art der Erhaltungstherapie mit synthetischen Opioiden. Psychiatr Psychother. 2006;2:39-52.
7. Veilleux JC, Colvin PJ, Anderson J, et al. A reviewof opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev. 2010;30:155-166.
8. Winstock A, Lintzeris N, Lea T. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment [published online ahead of print]. Int J Drug Policy. 2011;22(1):77-81.
9. Amato L, Davoli M, Minozzi S, et al. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev. 2005;(3):CD003409.
10. Gowing L, Ali R, White JM. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev. 2009;(3): CD002025.
11. Meader N. A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis. Drug Alcohol Depend. 2010;108:110-114.
12. Seifert J, Metzner C, Paetzold W, et al. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone. Pharmacopsychiatry. 2002;35:159-164.
13. Dimsdale JE, Norman D, DeJardin D, et al. The effect of opioids on sleep architecture. J Clin Sleep Med. 2007;3:33-36. (Pubitemid 46761006)
14. Kripke DF, Mullaney DJ, Messin S, et al. Wrist actigraphic measures of sleep and rhythms. Electroencephalogr Clin Neurophysiol. 1978;44:674-676. (Pubitemid 8353489)
15. Tryon WW. Activity Measurement in Psychology and Medicine. New York: Plenum; 1991.
16. Sadeh A, Hauri PJ, Kripke DF, et al. The role of actigraphy in the evaluation of sleep disorders. Sleep. 1995;18:288-302.
17. American Sleep Disorders Association. Practice parameters for the use of actigraphy in the clinical assessment of sleep disorders. Sleep. 1995;18:285-287.
18. Kripke DF, Mullaney DJ, Atkinson M, et al. Circadian rhythm disorders in manic-depressives. Biol Psychiatry. 1978;13:335-350.
19. Satlin A, Teicher MH, Lieberman HR, et al. Circadian locomotor activity rhythms in Alzheimer's disease. Neuropsychopharmacology. 1991;5:115-126.
20. Winkler D, Pjrek E, Pezawas L, et al. Relationship between power spectra of the awake EEG and psychomotor activity patterns measured by short-term actigraphy. Neuropsychobiology. 2003;48:176-181. (Pubitemid 37548223)
21. Winkler D, Pjrek E, Praschak-Rieder N, et al. Actigraphy in patients with seasonal affective disorder and healthy controls treated with light therapy. Biol Psychiatry. 2005;58:331-336. (Pubitemid 41133627)
22. Brown AC, Smolensky MH, D'Alonzo GE, et al. Actigraphy: a means of assessing circadian patterns in human activity. Chronobiol Int. 1990;7:125-133. (Pubitemid 20318244)
23. Lieberman HR, Wurtman JJ, Teicher MH. Circadian rhythms of activity in healthy young and elderly humans. Neurobiol Aging. 1989;10: 259-265. (Pubitemid 19180196)
24. O'Brien C, Hunt R, Jeffery HE. Measurement of movement is an objective method to assist in assessment of opiate withdrawal in newborns. Arch Dis Child Fetal Neonatal Ed. 2004;89: F305-F309. (Pubitemid 38869668)
25. Bundesgesetzblatt fü r die Republik Ö sterreich. Bundesgesetz über die Unterbringung psychisch Kranker in Krankenanstalten (UnterbringungsgesetzVUbG). Vienna, Austria: Ö sterreichische Staatsdruckerei; 1990.
26. Bundesgesetzblatt fü r die Republik Ö sterreich. Bundesgesetz über die Herstellung und das Inverkehrbringen von Arzneimitteln (Arzneimittelgesetz). Vienna, Austria: Ö sterreichische Staatsdruckerei; 1983.
27. Scheurich A, Muller MJ, Wetzel H, et al. Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). J Stud Alcohol. 2000;61:916-919.
28. Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90:607-614.
29. McLellan AT, Kushner H, Metzger D, et al. The FIFTH EDITION OF the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199-213.
30. Gossop M. The development of a Short Opiate Withdrawal Scale (SOWS). Addict Behav. 1990;15:487-490. (Pubitemid 20333437)
31. Bradley B, Gossop M, Phillips G, et al. The development of an opiate withdrawal scale. Br J Addict. 1987;82:1139-1142.
32. Cambridge Neurotechnology Ltd. Actiwatch Sleep Analysis 2001 Software. Version 1.19. Cambridgeshire, UK: Cambridge Neurotechnology Ltd; 2001.
33. Van Someren EJW, Swaab DF, Colenda CC, et al. Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of non-parametric methods. Chronobiol Int. 1999;16:505-518. (Pubitemid 29362572)
34. Nelson W, Tong IL, Lee JK, et al. Methods for cosinor-rhythmometry. Chronobiologia. 1979;6:305-323.
35. Kushida CA, Chang A, Gadkary C, et al. Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Sleep. 2001;2:389-396. (Pubitemid 32952342)
36. The R Project for Statistical Computing. R Version 2.11.0; 2010. Available at: http://www.r-project.org/. Accessed November 5, 2011.
37. Aubert-Tulkens G, Culée C, Harmant-Van Rijckevorsel K, et al. Ambulatory evaluation of sleep disturbance and therapeutic effects in sleep apnea syndrome by wrist activity monitoring. Am Rev Respir Dis. 1987;136:851-856. (Pubitemid 18028607)
38. Lichstein KL, Stone KC, Donaldson J, et al. Actigraphy validation with insomnia. Sleep. 2006;29:232-239. (Pubitemid 44019977)
39. Oakley NR. Validation With Polysomnography of the Sleep-Watch Sleep/Wake Scoring Algorithm Used by the Actiwatch Activity Monitoring System. Bend, OR: Mini Mitter Co, Inc; 1997. Technical Report to Mini Mitter Co, Inc.
40. Rotem AY, Sperber AD, Krugliak P, et al. Polysomnographic and actigraphic evidence of sleep fragmentation in patients with irritable bowel syndrome. Sleep. 2003;26:747-752. (Pubitemid 39619787)
41. Thomas KA, Burr RL. Circadian research in mothers and infants: how many days of actigraphy data are needed to fit cosinor parameters? J Nurs Meas. 2008;16:201-206.
42. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.
43. Gossop M, Bradley B, Phillips GT. An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure. Addict Behav. 1987;12:1-6. (Pubitemid 17000635)
44. Seifert J, Metzner C, Paetzold W, et al. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone. Addict Biol. 2005;10:157-164. (Pubitemid 40976385)
45. Daimon K, Yamada N, Tsujimoto T, et al. Circadian rhythm abnormalities of deep body temperature in depressive disorders. J Affect Disord. 1992;26:191-198.